Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

IQVIA Hldgs Corp a un objectif de cours consensuel de 567,61 $ basé sur les notes de 38 analystes. Le plus haut est de 1 350 $ émis par HSBC le 10 mai 2024<. Le plus bas est de 100 $ émis par Deutsche Bank le 5 août 2024. Les 3 dernières notations d'analystes ont été publiées par New Street Research, Goldman Sachs et Deutsche Bank respectivement le 6 août 2024, le 5 août 2024 et le 5 août 2024. Avec un objectif de cours moyen de 118,33 $ entre New Street Research, Goldman Sachs et Deutsche Bank, il existe une hausse implicite de 0,21 % pour IQVIA Hldgs Corp à partir de ces notations d'analystes les plus récentes.
1calculé à partir des notes des analystes
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
10/29/2025 | — | Citigroup | $200 → $230 | Maintains | Neutral | |||
10/29/2025 | — | UBS | $225 → $250 | Maintains | Buy | |||
10/29/2025 | — | Stifel | $234 → $254 | Maintains | Buy | |||
10/29/2025 | — | Truist Securities | $235 → $265 | Reiterates | Buy → Buy | |||
10/29/2025 | — | JP Morgan | $177 → $255 | Maintains | Overweight | |||
10/29/2025 | — | Baird | $224 → $258 | Upgrade | Neutral → Outperform | |||
10/09/2025 | — | HSBC | $195 → $235 | Upgrade | Hold → Buy | |||
10/08/2025 | — | Evercore ISI Group | $220 → $240 | Maintains | Outperform | |||
10/02/2025 | — | Barclays | $185 → $200 | Maintains | Equal-Weight | |||
09/09/2025 | — | Jefferies | $195 → $225 | Upgrade | Hold → Buy | |||
07/25/2025 | — | Mizuho | $190 → $225 | Maintains | Outperform | |||
07/23/2025 | — | Citigroup | $160 → $200 | Maintains | Neutral | |||
07/23/2025 | — | UBS | $185 → $225 | Maintains | Buy | |||
07/23/2025 | — | Truist Securities | $209 → $235 | Maintains | Buy | |||
07/23/2025 | — | Barclays | $165 → $185 | Maintains | Equal-Weight | |||
07/23/2025 | — | Baird | $159 → $196 | Maintains | Neutral | |||
07/09/2025 | — | Evercore ISI Group | $170 → $180 | Maintains | Outperform | |||
05/19/2025 | — | JP Morgan | $232 → $177 | Maintains | Overweight | |||
05/15/2025 | — | Mizuho | $210 → $190 | Maintains | Outperform | |||
05/07/2025 | — | Citigroup | $210 → $160 | Maintains | Neutral | |||
05/07/2025 | — | Baird | $195 → $161 | Maintains | Neutral | |||
05/07/2025 | — | UBS | $255 → $185 | Maintains | Buy | |||
05/07/2025 | — | Barclays | $170 → $165 | Maintains | Equal-Weight | |||
04/25/2025 | — | HSBC | $260 → $160 | Downgrade | Buy → Hold | |||
04/10/2025 | — | Truist Securities | $263 → $216 | Maintains | Buy | |||
04/10/2025 | — | Barclays | $235 → $170 | Downgrade | Overweight → Equal-Weight | |||
04/09/2025 | — | Mizuho | $242 → $210 | Maintains | Outperform | |||
03/04/2025 | — | Citigroup | $225 → $210 | Maintains | Neutral | |||
02/18/2025 | — | JP Morgan | $240 → $232 | Maintains | Overweight | |||
02/11/2025 | — | Morgan Stanley | $245 → $250 | Maintains | Overweight | |||
02/10/2025 | — | RBC Capital | $270 → $270 | Reiterates | Outperform → Outperform | |||
02/10/2025 | — | Truist Securities | $261 → $263 | Reiterates | Buy → Buy | |||
02/07/2025 | — | Stifel | $273 → $261 | Maintains | Buy | |||
02/07/2025 | — | UBS | $260 → $255 | Maintains | Buy | |||
02/03/2025 | — | Barclays | $255 → $235 | Maintains | Overweight | |||
01/21/2025 | — | Baird | $212 → $210 | Maintains | Neutral | |||
12/20/2024 | — | Stephens & Co. | → $250 | Initiates | → Overweight | |||
12/13/2024 | — | B of A Securities | $255 → $235 | Maintains | Buy | |||
12/12/2024 | — | Truist Securities | $265 → $261 | Maintains | Buy | |||
12/11/2024 | — | RBC Capital | $270 → $270 | Reiterates | Outperform → Outperform | |||
12/11/2024 | — | Baird | $213 → $212 | Maintains | Neutral | |||
12/04/2024 | — | RBC Capital | $270 → $270 | Reiterates | Outperform → Outperform | |||
11/19/2024 | — | Leerink Partners | $260 → $248 | Reiterates | Outperform → Outperform | |||
11/05/2024 | — | RBC Capital | $270 → $270 | Reiterates | Outperform → Outperform | |||
11/05/2024 | — | JP Morgan | $279 → $240 | Maintains | Overweight | |||
11/04/2024 | — | Truist Securities | $286 → $265 | Maintains | Buy | |||
11/04/2024 | — | Morgan Stanley | $280 → $265 | Maintains | Overweight | |||
11/01/2024 | — | UBS | $300 → $260 | Maintains | Buy | |||
11/01/2024 | — | BTIG | $290 → $260 | Maintains | Buy | |||
11/01/2024 | — | TD Cowen | — | $270 → $255 | Maintains | Buy | ||
11/01/2024 | — | Deutsche Bank | $270 → $265 | Maintains | Buy | |||
11/01/2024 | — | Barclays | $260 → $255 | Maintains | Overweight | |||
11/01/2024 | — | Goldman Sachs | $280 → $250 | Maintains | Buy | |||
11/01/2024 | — | RBC Capital | $270 → $270 | Reiterates | Outperform → Outperform | |||
11/01/2024 | — | Baird | $256 → $223 | Maintains | Neutral | |||
10/23/2024 | — | JP Morgan | $288 → $279 | Maintains | Overweight | |||
10/15/2024 | — | Barclays | $275 → $260 | Maintains | Overweight | |||
10/14/2024 | — | Redburn Atlantic | → $276 | Initiates | → Buy | |||
10/14/2024 | — | Truist Securities | $300 → $286 | Maintains | Buy | |||
10/08/2024 | — | Evercore ISI Group | $270 → $265 | Maintains | Outperform | |||
09/20/2024 | — | Baird | $251 → $256 | Maintains | Neutral | |||
09/04/2024 | — | RBC Capital | → $275 | Initiates | → Outperform | |||
08/05/2024 | — | JP Morgan | $260 → $288 | Maintains | Overweight | |||
07/24/2024 | — | Jefferies | $266 → $242 | Downgrade | Buy → Hold | |||
07/23/2024 | — | UBS | $295 → $300 | Maintains | Buy | |||
07/23/2024 | — | Morgan Stanley | $270 → $280 | Maintains | Overweight | |||
07/23/2024 | — | Truist Securities | $292 → $300 | Maintains | Buy | |||
07/23/2024 | — | Evercore ISI Group | $230 → $270 | Maintains | Outperform | |||
07/23/2024 | — | Barclays | $255 → $275 | Maintains | Overweight | |||
07/23/2024 | — | Baird | $235 → $251 | Maintains | Neutral | |||
07/10/2024 | — | Baird | $241 → $235 | Maintains | Neutral | |||
07/09/2024 | — | Evercore ISI Group | $250 → $230 | Maintains | Outperform | |||
06/28/2024 | — | Barclays | $275 → $255 | Maintains | Overweight | |||
06/06/2024 | — | Goldman Sachs | → $270 | Initiates | → Buy | |||
05/03/2024 | — | Evercore ISI Group | $275 → $250 | Maintains | Outperform | |||
05/03/2024 | — | Truist Securities | $297 → $292 | Maintains | Buy | |||
05/03/2024 | — | Baird | $254 → $245 | Maintains | Neutral | |||
02/27/2024 | — | Truist Securities | $286 → $297 | Maintains | Buy | |||
02/26/2024 | — | Leerink Partners | → $290 | Initiates | → Outperform | |||
02/15/2024 | — | UBS | $240 → $300 | Maintains | Buy | |||
02/15/2024 | — | Evercore ISI Group | $255 → $265 | Maintains | Market Outperform | |||
02/15/2024 | — | Baird | $226 → $251 | Maintains | Neutral | |||
02/15/2024 | — | Barclays | $260 → $265 | Maintains | Overweight | |||
02/15/2024 | — | Guggenheim | — | Downgrade | Buy → Neutral | |||
02/13/2024 | — | BTIG | → $285 | Initiates | → Buy | |||
01/25/2024 | — | Barclays | $215 → $260 | Maintains | Overweight | |||
01/18/2024 | — | Baird | $221 → $226 | Maintains | Neutral | |||
01/04/2024 | — | Truist Securities | $240 → $286 | Maintains | Buy | |||
12/11/2023 | — | Citigroup | $190 → $225 | Maintains | Neutral | |||
11/21/2023 | — | Truist Securities | → $240 | Reiterates | Buy → Buy | |||
11/13/2023 | — | JP Morgan | $262 → $239 | Maintains | Overweight | |||
11/03/2023 | — | Truist Securities | $260 → $240 | Maintains | Buy | |||
11/03/2023 | — | Guggenheim | $253 → $220 | Maintains | Buy | |||
11/03/2023 | — | Morgan Stanley | $240 → $225 | Maintains | Overweight | |||
11/02/2023 | — | Barclays | $245 → $215 | Maintains | Overweight | |||
11/02/2023 | — | Baird | $248 → $202 | Downgrade | Outperform → Neutral | |||
10/17/2023 | — | Baird | $239 → $248 | Maintains | Outperform | |||
10/10/2023 | — | Mizuho | $250 → $229 | Maintains | Buy | |||
10/03/2023 | — | Truist Securities | → $260 | Reiterates | Buy → Buy | |||
09/29/2023 | — | Barclays | $250 → $245 | Maintains | Overweight |
Le dernier objectif de prix pour IQVIA Hldgs (NYSE:IQV) a été rapporté par Citigroup le octobre 29, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $230.00 s'attendant à ce que IQV se rise dans les 12 prochains mois (un possible changement de 6.26% upside). 47 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
La dernière note d'analyste pour IQVIA Hldgs (NYSE:IQV) a été fournie par Citigroup, et IQVIA Hldgs maintenu leur note neutral.
La dernière amélioration pour IQVIA Holdings Inc a eu lieu le octobre 29, 2025 lorsque Baird a augmenté leur objectif de prix à $258. Baird avait précédemment a neutral pour IQVIA Holdings Inc.
La dernière réduction pour IQVIA Holdings Inc a eu lieu le avril 25, 2025 lorsque HSBC a changé leur objectif de prix de $260 à $160 pour IQVIA Holdings Inc.
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de IQVIA Hldgs, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour IQVIA Hldgs a été déposée le octobre 29, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers octobre 29, 2026.
Bien que les évaluations soient subjectives et changeront, la dernière note de IQVIA Hldgs (IQV) était un maintenu avec un objectif de prix de $200.00 à $230.00. Le prix actuel de IQVIA Hldgs (IQV) est de $216.46, ce qui est within la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.